» Authors » Fernanda Ramos-Delgado

Fernanda Ramos-Delgado

Explore the profile of Fernanda Ramos-Delgado including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 6
Citations 44
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Thibault B, Ramos-Delgado F, Guillermet-Guibert J
Cancers (Basel) . 2023 Feb; 15(3). PMID: 36765741
Phosphatidylinositol-3-kinase (PI3K) enzymes, producing signaling phosphoinositides at plasma and intracellular membranes, are key in intracellular signaling and vesicular trafficking pathways. PI3K is a family of eight enzymes divided into three...
2.
Cintas C, Douche T, Dantes Z, Mouton-Barbosa E, Bousquet M, Cayron C, et al.
Mol Cancer Ther . 2021 Sep; 20(12):2433-2445. PMID: 34552006
The PI3K pathway is highly active in human cancers. The four class I isoforms of PI3K are activated by distinct mechanisms leading to a common downstream signaling. Their downstream redundancy...
3.
Thibault B, Ramos-Delgado F, Pons-Tostivint E, Therville N, Cintas C, Arcucci S, et al.
EMBO Mol Med . 2021 May; 13(7):e13502. PMID: 34033220
Pancreatic ductal adenocarcinoma (PDAC) patients frequently suffer from undetected micro-metastatic disease. This clinical situation would greatly benefit from additional investigation. Therefore, we set out to identify key signalling events that...
4.
Arcucci S, Ramos-Delgado F, Cayron C, Therville N, Gratacap M, Basset C, et al.
Biochem J . 2021 Mar; 478(6):1199-1225. PMID: 33740047
PI3Ks are important lipid kinases that produce phosphoinositides phosphorylated in position 3 of the inositol ring. There are three classes of PI3Ks: class I PI3Ks produce PIP3 at plasma membrane...
5.
Therville N, Arcucci S, Vertut A, Ramos-Delgado F, Ferreira Da Mota D, Dufresne M, et al.
Theranostics . 2019 Oct; 9(22):6369-6379. PMID: 31588223
Rapid, easy and early pancreatic cancer diagnosis and therapeutic follow up continue to necessitate an increasing attention towards the development of effective treatment strategies for this lethal disease. The non...
6.
Cintas C, Douche T, Therville N, Arcucci S, Ramos-Delgado F, Basset C, et al.
Cancers (Basel) . 2018 Jun; 10(6). PMID: 29865155
For patients with metastatic pancreatic cancer that are not eligible for surgery, signal-targeted therapies have so far failed to significantly improve survival. These therapeutic options have been tested in phase...